# A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.

> **NCT01941966** · PHASE2 · COMPLETED · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 51 (estimated)

## Conditions studied

- Anal Canal Cancer.

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Mitomycins
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01941966
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2013-11
- **Final completion:** —
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2014-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941966, "A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal.". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01941966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*